B Group, Inc.
CIK: 0002043476Latest portfolio: $135.4M · Q4 2025
Holdings
16
Total Value
$135.4M
New Positions
2
Closed Positions
6
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ADMAADMA BIOLOGICS INC | 2,457,542 | $44.8M | 33.10% | +45K | |
| 2 | CLLSCELLECTIS S A | 3,281,501 | $15.9M | 11.73% | — | |
| 3 | PALIPALISADE BIO INC | 4,500,000 | $10.6M | 7.81% | NEW | |
| 4 | TSHATAYSHA GENE THERAPIES INC | 1,800,556 | $9.9M | 7.31% | — | |
| 5 | PRAXPRAXIS PRECISION MEDICINES I | 33,237 | $9.8M | 7.23% | +2K | |
| 6 | SGHTSIGHT SCIENCES INC | 920,000 | $7.3M | 5.39% | -10,000 | |
| 7 | ZLABZAI LAB LTD | 400,000 | $7.1M | 5.21% | — | |
| 8 | GPCRSTRUCTURE THERAPEUTICS INC | 90,000 | $6.3M | 4.62% | NEW | |
| 9 | ASMBASSEMBLY BIOSCIENCES INC | 175,706 | $6.0M | 4.41% | — | |
| 10 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,500,000 | $4.1M | 3.02% | — | |
| 11 | SYRESPYRE THERAPEUTICS INC | 100,000 | $3.3M | 2.42% | — | |
| 12 | AURAAURA BIOSCIENCES INC | 572,576 | $3.1M | 2.30% | — | |
| 13 | RAREULTRAGENYX PHARMACEUTICAL IN | 135,000 | $3.1M | 2.29% | — | |
| 14 | ORKAORUKA THERAPEUTICS INC | 75,000 | $2.3M | 1.68% | — | |
| 15 | APGEAPOGEE THERAPEUTICS INC | 20,000 | $1.5M | 1.11% | -15,000 | |
| 16 | REPLREPLIMUNE GROUP INC | 50,000 | $486K | 0.36% | — | Call |
Quarterly Changes
Sector Breakdown
Healthcare100.0% ($4.48251588210576e+56T)
Filing History
Fund Information
B Group, Inc. is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $135.4M across 16 holdings. The largest position is ADMA BIOLOGICS INC (ADMA), representing 33.1% of the portfolio. Compared to the previous quarter, the fund opened 2 new positions and closed 6 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.